Acyclovir ImpI is a synthetic byproduct arising from the acyclic nucleoside pathway of aciclovir production. It features a substituted purine core fused to a modified cyclopropane ring, with an additional methylene bridge and a terminal hydroxyl group compared to the parent drug. The molecule contains four amino functionalities, two heterocyclic nitrogen atoms, and a phosphorylated sugar analog moiety. Its structural divergence from aciclovir includes an extra carbonyl group in the side chain, which disrupts the canonical hydrogen-bonding pattern. This impurity serves as an HPLC reference standard for quantifying process-related deviations in aciclovir API batches.
On RequestC1=NC2=C(N1COCCOCN3C=NC4=C3C(=O)NC(=N4)N)N=C(NC2=O)N
InChI=1S/C14H16N10O4/c15-13-19-9-8(12(26)22-13)23(4-18-9)5-27-1-2-28-6-24-3-17-7-10(24)20-14(16)21-11(7)25/h3-4H,1-2,5-6H2,(H3,15,19,22,26)(H3,16,20,21,25)
ZKDRLENQIACTMV-UHFFFAOYSA-N